We set new standards in the expression of heterologous glycoproteins
EUGENEX developed a well-characterized expression system
(cell lines, vector, media) to serve the customer's needs for
in the production of pure heterologous glycoproteins for research,
diagnostics and therapeutic applications.
The absence of serum and animal-derived components during all steps
of development increases biosafety and leads to safer products in
Beside economical and biosafety aspects there are also ethical consideration
concerning the use of fetal bovine serum.
Klick here and
learn more about the harvest procedure of FBS.